BCI Marketplace
Transcranial Magnetic Stimulation trials

Effect of Transcranial Magnetic Stimulation on Visual Functions of Adult Amblyopia: a Preliminary Study

RecruitingNCT05393739Phase: NAStarted 2023-01-05

Summary

Amblyopia, with a prevalence rates of 3% in adult population, is a common cause of vision impairment. It is characterized by impaired vision in one or both eyes because of disruption of normal visual stimuli and underdevelopment of the visual cortex, leads to lifelong visual deficits affecting both monocular and binocular visual function. Common causes of amblyopia include refraction error, anisometropia, strabismus and visual deprivation arising from ptosis or congenital cataract. Our previous

Eligibility

Sex
ALL
Min Age
20 Years
Max Age
50 Years

Inclusion Criteria: 1. Adult amblyopia participants, aged 20-50 years old. 2. Based on inclusion criteria, there was a minimum of 2 lines difference in BCVA between the 2 eyes. 3. An amblyogenic factor and history of amblyopia treatment was recorded Exclusion Criteria: 1. Unstable vital sign 2. H

Locations

National Taiwan University Hospital
Taipei County, Taiwan

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →